Pages that link to "Q55070063"
Jump to navigation
Jump to search
The following pages link to Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease. (Q55070063):
Displaying 50 items.
- ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma (Q26777288) (← links)
- Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies (Q28071258) (← links)
- Diffuse Cystic Lung Disease. Part I. (Q33722950) (← links)
- Langerhans cell histiocytosis in children: from the bench to bedside for an updated therapy (Q34515611) (← links)
- Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report (Q35618455) (← links)
- Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study. (Q36219698) (← links)
- A Rare Case of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome. (Q36249526) (← links)
- Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1. (Q36260647) (← links)
- Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. (Q36553791) (← links)
- Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. (Q36887654) (← links)
- Long-term outcome of basilar stenosis in Erdheim-Chester disease: A case report (Q37257050) (← links)
- The distribution of BRAF gene fusions in solid tumors and response to targeted therapy (Q37308973) (← links)
- Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA. (Q37394955) (← links)
- Systemic vasculitis associated with vemurafenib treatment: Case report and literature review (Q37432850) (← links)
- Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages (Q37509422) (← links)
- Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease (Q37613717) (← links)
- BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy (Q37659076) (← links)
- Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH Trial. (Q38371672) (← links)
- BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment (Q38569221) (← links)
- High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis. (Q38692332) (← links)
- Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease (Q38700671) (← links)
- Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells (Q38752592) (← links)
- Histiocytic neoplasms in the era of personalized genomic medicine (Q38814135) (← links)
- Erdheim-Chester Disease as a Mimic of IgG4-Related Disease: A Case Report and a Review of a Single-Center Cohort (Q38844874) (← links)
- Histiocytoses: emerging neoplasia behind inflammation (Q39142018) (← links)
- Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease (Q39397373) (← links)
- Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms (Q39411958) (← links)
- Rare form of erdheim-chester disease presenting with isolated central skeletal lesions treated with a combination of alfa-interferon and zoledronic Acid. (Q39928580) (← links)
- Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults. (Q40921309) (← links)
- Erdheim-Chester Disease: The Importance of Information Integration (Q41488473) (← links)
- Langerhans cell histiocytosis of the maxillae in a child treated only with chemotherapy: a case report (Q41896408) (← links)
- Erdheim-Chester Disease With Multiorgan Involvement, Following Polycythemia Vera: A Case Report (Q41960157) (← links)
- Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas. (Q42515742) (← links)
- Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study. (Q46031169) (← links)
- RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions (Q47269284) (← links)
- Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease (Q47368970) (← links)
- CNS Erdheim-Chester Disease: A Challenge to Diagnose (Q47592137) (← links)
- Erdheim-Chester disease: yellow-tinge appearance on neuroendoscopic imaging. (Q48159142) (← links)
- Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease. (Q48198264) (← links)
- A cytologic diagnosis of BRAFV600E Erdheim-Chester disease on pericardial fluid. (Q48211955) (← links)
- Intracranial Erdheim-Chester Disease mimicking parafalcine meningioma: report of two cases and review of the literature. (Q49390060) (← links)
- Single-agent dabrafenib for BRAFV600E-mutated histiocytosis. (Q52689208) (← links)
- Tocilizumab in patients with multisystem Erdheim-Chester disease. (Q52763513) (← links)
- Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease. (Q54171656) (← links)
- Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies. (Q54203888) (← links)
- Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling. (Q55402884) (← links)
- Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report (Q57284517) (← links)
- The clinical spectrum of Erdheim-Chester disease: an observational cohort study (Q57453129) (← links)
- Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease (Q58605423) (← links)
- Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan (Q59810091) (← links)